Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists

Biochemical and Biophysical Research Communications

Volumn 243, Issue 1, 1998, Pages 41-46

  Kukkonen, Jyrki P ^a,b   Näsman, Johnny ^a,b   Rinken, Ago ^c   Dementjev, Anton ^c   Åkerman, Karl E O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CELL LINE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032481270     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.8054     Document Type: Article

References (25)

1. Rang H. P. Proc. R. Soc. Lond. B Biol. Sci. 164:1966;488-510.
2. El-Fakahany E. E., Surichamorn W., Amrhein C. L., Stenstrom S., Cioffi C. L., Richelson E., McKinney M. J. Pharmacol. Exp. Ther. 247:1988;934-940.
3. Kachur J. F., Allbee W. E., Gaginella T. S. J. Pharmacol. Exp. Ther. 245:1988;455-459.
4. Kenakin T. P., Boselli C. Eur. J. Pharmacol. 191:1990;39-48.
5. Patscheke H. Stroke. 21:1990;IV139-142.
6. Minneman K. P., Atkinson B. Mol. Pharmacol. 40:1991;523-530.
7. Kukkonen J., Åkerman K. E. O. Biochem. Biophys. Res. Commun. 189:1992;919-924.
8. Vigne P., Breittmayer J. P., Frelin C. Eur. J. Pharmacol. 245:1993;229-232.
9. Sakamoto A., Yanagisawa M., Tsujimoto G., Nakao K., Toyo oka T., Masaki T. Biochem. Biophys. Res. Commun. 200:1994;679-686.
10. Kukkonen J. P., Huifang G., Jansson C. C., Wurster S., Cockcroft V., Savola J. M., Åkerman K. E. O. Eur. J. Pharmacol. 335:1997;99-105.
11. Kenakin T. Pharmacologic Analysis of Drug-Receptor Interaction. 1993;Raven Press, New York.
12. Kukkonen J. P., Näsman J., Ojala P., Oker-Blom C., Åkerman K. E. O. J. Pharmacol. Exp. Ther. 279:1996;593-601.
13. Peterson G. L. Methods Enzymol. 91:1983;95-119.
14. Cornish Bowden A. Biochem. J. 137:1974;143-144.
15. Gosselin R. E. Br J Pharmacol. 39:1970;215P.
16. Gosselin R. E. Kinetics of Drug Action. 1977;Springer-Verlag, Berlin. p. 283-335.
17. Paton W. D. M. Proc Roy Soc Lond B. 154:1961;21-69.
18. Mendes P. Comput. Appl. Biosci. 9:1993;563-571.
19. Hu Y., Rajan L., Schilling W. P. Am. J. Physiol. 266:1994;C1736-1743.
20. Ellis J., Huyler J., Brann M. R. Biochem. Pharmacol. 42:1991;1927-1932.
21. Taylor C. W. Biochem. J. 272:1990;1-13.
22. Lee S. B., Rhee S. G. Curr. Opin. Cell Biol. 7:1995;183-189.
23. Bezprozvanny I., Watras J., Ehrlich B. E. Nature. 351:1991;751-754.
24. Bootman M. D., Missiaen L., Parys J. B., De Smedt H., Casteels R. Biochem. J. 306:1995;445-451.
25. Miyazaki S. Curr. Opin. Cell Biol. 7:1995;190-196.